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ender, Race, and Cardiac Care
hy the Differences?*
ita F. Redberg, MD, MSC, FACC
an Francisco, California
his reality is common to men and women in the U.S. of all
aces: they all are more likely to die from heart disease than
ny other cause (1). Beyond this commonality, however, lie
ubstantial variations in cardiac care according to gender
nd race. In 2002, a comprehensive review of studies about
isparities by the Kaiser Family Foundation and the Amer-
can College of Cardiology Foundation (2) found significant
ifferences in cardiac care for minority groups. According to
hese studies, African-American patients, for example, are
ess likely than white patients to undergo diagnostic tests
nd revascularization, even after controlling for clinical and
ocioeconomic factors. The Kaiser findings mirrored a 2002
nstitute of Medicine report (3) that concluded that racial/
thnic variations in medical care are widespread.
See pages 1838 and 1845
Disparities by gender also are well documented: Women
re diagnosed later than men and receive fewer therapies (4).
omen receive fewer coronary angiography and revascular-
zation procedures (5), and women have higher complica-
ion and mortality rates after revascularization (6,7).
The congressionally mandated National Healthcare Dis-
arities Reports found that such disparities result from
omplex factors with many contributors and no single cause
8). Factors may include: 1) that certain minority groups
ave more risk factors and are less healthy in general; 2) that
he course of cardiac disease is different in different sub-
roups; 3) that physicians are biased in their recommenda-
ions; and/or 4) that women and minorities tend to decline
ertain treatment options. Surprisingly, most cardiologists
re unaware of race and gender disparities in treatment (9).
o help educate health professionals about disparities and
dentify and develop strategies to reduce gaps in care based
n race and culture, the American College of Cardiology,
he American Medical Association, and others recently have
ormed the Commission to End Health Care Disparities
10).
Differences in care do not necessarily mean inferior care if
hey are based on differences in patient characteristics. In
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the School of Medicine, Division of Cardiology, University of California,
an Francisco, California Dr. Redberg is supported in part by the Robert Woodd
ohnson Foundation Health Policy Fellowship and by the Flight Attendant Medical
esearch Institute.ddition, more care is not always better care, as first
emonstrated more than 30 years ago by Wennberg and
ittelsohn (11) and more recently by Fisher et al. (12,13).
e can agree, however, that the most egregious reason for
ifferences would be bias—conscious or unconscious.
athore and Krumholz (14) suggest a framework for cate-
orizing variations in care into three tiers: differences,
isparities, and biases. Variations in care can be considered
disparities” if: 1) the difference in health care reflects
hortfalls in appropriate care that cannot be explained by
ther patient factors, and 2) there are associated adverse
ealth consequences. “Bias” would apply to disparities that
annot be explained by health system factors (provider
haracteristics).
ENDER DISPARITIES IN THE CURE TRIAL
his issue of the Journal includes two papers (15,16) with
ew insights on disparities in care of patients with acute
oronary syndrome (ACS). Anand et al. (15) performed a
ost-hoc analysis of gender differences in the management
nd outcomes of patients with ACS from the Clopidogrel in
nstable Angina to Prevent Recurrent Events (CURE)
rial. The authors compared the outcomes of the 4,836
omen and 7,726 men from 28 countries who suffered ACS
uring the period of December 1998 and October 2000.
he researchers examined the use of invasive procedures,
evascularization rates, and incidence of death, myocardial
nfarction (MI), or stroke after approximately nine months.
he primary composite end point—stroke, MI, or cardio-
ascular death—was similar in women (4.4%) and men
4.9%).
Although the end point for women and men was nearly
he same, there were significant disparities in treatment. For
xample, women with ACS were less likely to receive
oronary angiography than men (25.4% vs. 29.5%, respec-
ively). Interestingly, the women in the CURE trial receiv-
ng angiography were twice as likely to have normal coro-
aries (26.7% normal in women vs. 13.2% normal in men)
15). One is tempted to conclude, therefore, that fewer
omen undergo angiography because women are less likely
o have cardiac disease. However, the authors found that the
robability of a woman being referred for angiography was
nrelated to her Thrombolysis In Myocardial Infarction
TIMI) risk score, that is, high-risk women were not more
ikely to be referred to angiography than low-risk women.
The findings in the CURE study suggest, therefore, that
he differences in referral to angiography are due to bias, not
ealth factors. Thus, the general perception that women are
t lower risk for heart disease may negatively impact the care
f high-risk women. (Note, however, that a limitation of the
URE study is that the authors did not address whether
ngiography in women was related to better outcomes.)
The Anand et al. (15) study provides evidence that the
isparity in treatment of women with ACS derives not from
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November 15, 2005:1852–4 Editorial Commentifferences in the disease itself but rather from physician
ecisions unrelated to risk assessment. Of course, risk
tratification, not physician bias, should determine how
ggressive cardiac treatment should be in individual women,
ust as in men, even though women are at lower risk as a
roup.
ACE DISPARITIES IN KANSAS CITY
pertus et al. (16) report results of an observational study
omparing one-year outcomes, measuring quality of life and
hysical function, between African-American and white
atients in Kansas City. From an ACS registry, the re-
earchers used the Seattle Angina Questionnaire and the
hort Form (SF)-12 to interview patients admitted with
CS at two hospitals from March 2001 to October 2002.
ollow-up interviews were used to assess the patients’
linical and health status one year later. The authors also
ooked at rates of revascularization by race. On average, the
frican-American patients (196 of 1,159, or 17%), although
ounger, were more likely to suffer from diabetes, hyperten-
ion, obesity, and renal failure and to smoke.
The African-American patients started with essentially
he same baseline quality of life as white patients (approx-
mately 50 Seattle Angina Questionnaire [SAQ]), but with
lightly lower physical function measures than whites (ap-
roximately 37 SF-12 vs. approximately 39 SF-12; Fig. 1B
f the Spertus et al. paper [16]). After one year, both groups
njoyed improved quality of life, although the improvement
or African-American patients was significantly less than for
he white patients (70.6 SAQ vs. 83.9 SAQ). Distressingly,
he African-American patients’ physical function actually
ecreased after one year (to 36.8 SF-12; Fig. 1C of the
pertus et al. paper [16]) and lagged substantially behind
he white patients, who improved in physical function (to
3.2 SF-12). These differences remained after adjusting for
edical conditions and sociodemographic factors.
Higher revascularization rates in white patients did not
xplain their higher quality of life and physical function
cores. It appears that comorbidities or other unmeasured
actors (perhaps relating to care of patients between dis-
harge and one year) are responsible for the disparate scores.
he authors suggest, rightly, that future investigation
hould examine outpatient treatments, compliance with
edications, and biologic mechanisms that might explain
he disparities. A limitation of this study is that the authors
id not adjust for hospital factors; if the white patients were
reated primarily at one of the two hospitals in the study and
frican-American patients mostly at the other, hospital
haracteristics may also account for the differences found in
he study. Nevertheless, the study offers important new data
n racial differences in quality of life in patients with ACS.
ROCESS MEASURES VERSUS OUTCOME MEASURES
edical care in general, and cardiac care in particular, may
e assessed by using direct outcome measures (i.e., how well fr how long patients actually live), or by using “process”
easures (i.e., measures of procedures or treatments as
ndirect indicators of health and outcomes). The validity of
rocess measures depends on how well they correlate to
utcomes. Processes, such as therapies or procedures, are
aluable only if they lead to improved quality and/or
uantity of life. Most quality indicators in cardiology studies
re process measures, such as the administration of drugs
e.g., acetylsalicylic acid, beta-blockers, angiotensin-
onverting enzyme inhibitors) (17) or measurement of
jection fraction in patients admitted for heart failure (18).
hese process measures are presumed to lead to improved
utcomes, such as a decrease in rates of myocardial infarc-
ion and death and, indeed, many studies show these
reatments are associated with improved outcomes.
However, data to support the association of process
easures and outcomes are more limited for women and
inority populations as the result of lower enrollment in
linical trials. These missing data are crucial. For example,
lthough initial trials showed benefit of glycoprotein IIb/
IIa inhibitors in men with ACS, a meta-analysis of six
CS studies found no benefit of glycoprotein IIb/IIIa
nhibitors in women and, more alarmingly, a 15% increased
isk of MI and death (19).
O DIFFERENCES IN THE COURSE OF CARDIAC
ISEASE EXPLAIN DISPARITIES?
ifferent cardiac care for certain subgroups can be appro-
riate, based on different patient risk profiles and/or dem-
nstrated differences in outcomes. Differences in treatment,
y gender, when based on reliable gender-specific data,
hould be reassuring, not disturbing. Race disparities, on the
ther hand, present a more troubling case, because they
ppear to be associated with many factors, such as insurance
tatus, treatment facility, and geographic neighborhood
20). More research is needed.
O WOMEN AND MINORITIES CHOOSE TO HAVE
EWER PROCEDURES?
nother possible explanation for some differences in treat-
ent is patient choice. It is well documented that ethnic
inorities and women are less likely to receive some types of
are (21,22). It is unclear, however, whether women and
inorities are less likely to be offered certain procedures or
imply are less likely to agree to have them. At least one
tudy found that women are more willing than men to
ndergo invasive cardiac procedures (23), suggesting that
ewer cardiac catheterizations in women are due to fewer
ecommendations for the procedure. Another study of
atient refusal in the use of coronary angiography in
ost-MIMedicare beneficiaries, however, found that elderly
emale and black patients are slightly more likely to refuse
ngiography than male and white patients (24). However,
atient refusal overall is uncommon and accounts for only a
raction of observed race and gender differences.
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Editorial Comment November 15, 2005:1852–4OW CONCERNED SHOULD WE BE
VER DISPARITIES?
he articles in this issue of the Journal again confirm that
here are racial- and gender-based disparities in cardiovas-
ular care, and their conclusions leave us with several areas
or future exploration. Both studies showed lower rates of
evascularization in female and African-American patients
hat were not related to outcomes differences. Women and
inorities had poorer quality of life indicators, poorer
hysical function (16), and higher rates of rehospitalization
or angina (15), but no difference in hard outcomes (myo-
ardial infarction or death). It is important to have such
utcomes data; using process measures as surrogates for
utcomes data is less reliable in women and minorities
ecause data for these groups are so limited. Including more
omen and minorities in clinical trials and including
ender- and race-specific reporting in medical journals
ould greatly help us to understand the reasons for race and
ender disparities in health care.
eprint requests and correspondence: Dr. Rita F. Redberg,
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